Search results
What the papers say – May 31
Press Association News via AOL· 2 days agoMay 30, 2024 Voters are braced for tax increases despite assurances from both parties they will notincrease VAT, according to the Financial Times. Just...
Reaching absolute zero for quantum computing now much quicker thanks to breakthrough refrigerator...
LiveScience· 6 days agoA breakthrough cooling technology could help invigorate quantum computing and slash costly...
Fluent BioSciences Debuts PIPseq™ V with Unique Molecular Counting Strategy
WPRI Providence· 3 days agoFluent BioSciences, a leader in single-cell technology innovation, is proud to herald the launch of our latest product line, the PIPseq V 3' Single Cell RNA Sequencing Kits. This new release ...
Iran’s fragile political future after Raisi’s death: A leadership vacuum
The Hill· 1 day agoThe recent unexpected death of Iranian President Ebrahim Raisi has starkly exposed the fragile state...
Roche Blood Test for Lp(a) Designated Breakthrough Device
Medscape· 4 days agoA blood test that measures lipoprotein(a) [Lp(a)] has received breakthrough device designation from...
Data centres could use 9% of US electricity by 2030 as AI grows, says institute
Verdict via Yahoo Finance· 2 days ago“This could lead to an excessive strain on existing energy resources and potentially contribute to...
Arsenal ‘Firmly in the Mix’ to sign £51m Star
GiveMeSport· 18 hours agoArsenal are very much in the mix to sign RB Leipzig striker, journalist Ben Jacobs has told GIVEMESPORT. The Slovenia international has enjoyed a ...
In Chatham County, it's 'growth, growth, growth.' But will Biden reap the benefit?
WUNC Chapel Hill· 5 days agoAt the epicenter of President Joe Biden's promised economic boom, a slow tractor can still halt traffic. The new Wolfspeed factory — six football fields long — overlooks U.S. Highway 64 and ...
Ionis reveals an oasis for HAE patients as RNA med reduces attacks in phase 3
FierceBiotech· 1 day agoEarlier this year, the company announced that donidalorsen had met the primary endpoint of a phase 3...
Ionis presents positive results from OASIS-HAE and OASISplus studies of investigational medicine...
The Grass Valley Union· 2 days agoIonis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced positive results from the Phase 3 OASIS-HAE and OASISplus studies of donidalorsen in patients with hereditary angioedema (HAE) demonstrating significant and sustained reduction in mean monthly HAE attack rates and continued attack rate...
